Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years; 2. Diagnosed with malignant tumor, with no restrictions on tumor type, and receiving chemotherapy based on platinum compounds; 3. Expected survival period greater than 3 months; 4. ECOG score 0-2; 5. No other diseases causing nausea and vomiting, such as increased intracranial pressure, brain metastasis, intestinal obstruction or liver and kidney diseases, etc.; 6. No abnormal sense of smell or respiratory system diseases such as asthma or rhinitis in the patient; 7. Signed a written informed consent form and voluntarily agreed to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Allergic to the ingredients in this product; 2. Used other antiemetic drugs 24 hours before chemotherapy; 3. Having coagulation dysfunction; 4. Having severe cardiovascular diseases, liver and kidney dysfunction, respiratory system diseases or other infectious diseases; 5. Undergoing radiotherapy simultaneously; 6. Having received similar intervention measures within one month prior to the start of this study; 7. Impairments in activities, language, hearing, cognitive functions or mental disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ( Chemotherapy-Induced Nausea and Vomiting,CINV; | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional Living Index-Emesis; | — |
Countries
China
Contacts
Sun Yat-sen Memorial Hospital, Sun Yat-sen University